Longboard Pharmaceuticals Company Top Insiders
LBPH Stock | USD 59.80 0.03 0.05% |
Under 84 percent of Longboard Pharmaceuticals' insiders are selling. The analysis of the overall insider sentiment regarding Longboard Pharmaceuticals suggests that a large number of insiders are terrified. Longboard Pharmaceuticals employs about 50 people. The company is managed by 11 executives with a total tenure of roughly 117 years, averaging almost 10.0 years of service per executive, having 4.55 employees per reported executive.
Longboard Pharmaceuticals' Insider Buying Vs Selling
16
Selling | Buying |
Latest Trades
2024-10-15 | Randall Kaye | Disposed 16667 @ 59.03 | View | ||
2024-09-16 | Randall Kaye | Disposed 16666 @ 31.64 | View | ||
2024-08-12 | Randall Kaye | Disposed 16667 @ 34.73 | View | ||
2024-06-25 | Randall Kaye | Disposed 100 @ 20.87 | View | ||
2024-01-25 | Arena Pharmaceuticals Inc | Disposed 3978540 @ 24.25 | View | ||
2024-01-23 | Randall Kaye | Acquired 100 @ 24.82 | View |
Monitoring Longboard Pharmaceuticals' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Longboard |
Longboard Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.3072) % which means that it has lost $0.3072 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4666) %, meaning that it created substantial loss on money invested by shareholders. Longboard Pharmaceuticals' management efficiency ratios could be used to measure how well Longboard Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.13. The current Return On Capital Employed is estimated to decrease to -1.46. As of now, Longboard Pharmaceuticals' Total Current Assets are increasing as compared to previous years.The current Common Stock Shares Outstanding is estimated to decrease to about 20.5 M. The current Net Loss is estimated to decrease to about (41.5 M)
Longboard Pharmaceuticals Workforce Comparison
Longboard Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,662. Longboard Pharmaceuticals holds roughly 50.0 in number of employees claiming about 3% of equities under Health Care industry.
Longboard Pharmaceuticals Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Longboard Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Longboard Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Longboard Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 1.2 | 6 | 5 | 99,429 | 156,696 |
2024-09-01 | 0.4 | 4 | 10 | 115,815 | 149,148 |
2024-06-01 | 5.0 | 5 | 1 | 112,500 | 100.00 |
2024-03-01 | 6.0 | 6 | 1 | 563,384 | 3,978,540 |
2021-03-01 | 0.5556 | 5 | 9 | 190,559 | 985,822 |
Longboard Pharmaceuticals Notable Stakeholders
A Longboard Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Longboard Pharmaceuticals often face trade-offs trying to please all of them. Longboard Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Longboard Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dewey McLin | VP Affairs | Profile | |
Nuggehally Srinivas | VP Pharmacometrics | Profile | |
Anne Danks | VP Development | Profile | |
Jodi Parsons | VP Affairs | Profile | |
Chadwick MPH | Executive Operations | Profile | |
Steven JD | Head Counsel | Profile | |
Randall MD | Executive Officer | Profile | |
Megan Knight | Head Relations | Profile | |
Marco Peters | VP Science | Profile | |
Kevin Lind | CEO and President | Profile | |
Gus Cardenas | VP Assurance | Profile |
About Longboard Pharmaceuticals Management Performance
The success or failure of an entity such as Longboard Pharmaceuticals often depends on how effective the management is. Longboard Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Longboard management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Longboard management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.07) | (1.13) | |
Return On Capital Employed | (1.39) | (1.46) | |
Return On Assets | (1.07) | (1.13) | |
Return On Equity | (1.33) | (1.40) |
Longboard Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Longboard Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Longboard Pharmaceuticals within its industry.Longboard Pharmaceuticals Manpower Efficiency
Return on Longboard Pharmaceuticals Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.1M | |
Net Loss Per Executive | 4.9M | |
Working Capital Per Employee | 808.9K | |
Working Capital Per Executive | 3.7M |
Complementary Tools for Longboard Stock analysis
When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |